Literature DB >> 9305888

A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase.

R Stäsche1, S Hinderlich, C Weise, K Effertz, L Lucka, P Moormann, W Reutter.   

Abstract

N-Acetylneuraminic acid (Neu5Ac) is the precursor of sialic acids, a group of important molecules in biological recognition systems. Biosynthesis of Neu5Ac is initiated and regulated by its key enzyme, UDP-N-acetylglucosamine 2-epimerase (UDP-GlcNAc 2-epimerase, EC 5.1. 3.14)/N-acetylmannosamine kinase (ManNAc kinase, EC 2.7.1.60) in rat liver (Hinderlich, S., Stäsche, R., Zeitler, R., and Reutter, W. (1997) J. Biol. Chem. 272, 24313-24318). In the present paper we report the isolation and characterization of a cDNA clone encoding this bifunctional enzyme. An open reading frame of 2166 base pairs encodes 722 amino acids with a predicted molecular mass of 79 kDa. The deduced amino acid sequence contains exact matches of the sequences of five peptides derived from tryptic cleavage of the enzyme. The recombinant bifunctional enzyme was expressed in COS7 cells, where it displayed both epimerase and kinase activity. Distribution of UDP-GlcNAc 2-epimerase/ManNAc kinase in the cytosol of several rat tissues was investigated by determining both specific enzyme activities. Secreting organs (liver, salivary glands, and intestinal mucosa) showed high specific activities of UDP-GlcNAc 2-epimerase/ManNAc kinase, whereas significant levels of these activities were absent from other organs (lung, kidney, spleen, brain, heart, skeletal muscle, and testis). Northern blot analysis revealed no UDP-GlcNAc 2-epimerase/ManNAc kinase mRNA in the non-secreting tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305888     DOI: 10.1074/jbc.272.39.24319

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Enzymatic synthesis of nucleotide sugars.

Authors:  T Bülter; L Elling
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

2.  Sialylation is essential for early development in mice.

Authors:  Martina Schwarzkopf; Klaus-Peter Knobeloch; Elvira Rohde; Stephan Hinderlich; Nicola Wiechens; Lothar Lucka; Ivan Horak; Werner Reutter; Rüdiger Horstkorte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

3.  A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.

Authors:  Jared J Aumiller; Jason R Hollister; Donald L Jarvis
Journal:  Glycobiology       Date:  2003-02-20       Impact factor: 4.313

4.  Domain-specific characteristics of the bifunctional key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.

Authors:  Astrid Blume; Wenke Weidemann; Ulrich Stelzl; Erich E Wanker; Lothar Lucka; Peter Donner; Werner Reutter; Rüdiger Horstkorte; Stephan Hinderlich
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 5.  Sialylation in protostomes: a perspective from Drosophila genetics and biochemistry.

Authors:  Kate Koles; Elena Repnikova; Galina Pavlova; Leonid I Korochkin; Vladislav M Panin
Journal:  Glycoconj J       Date:  2008-06-21       Impact factor: 2.916

6.  Convergent pathways for utilization of the amino sugars N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid by Escherichia coli.

Authors:  J Plumbridge; E Vimr
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

Review 7.  KDN (deaminated neuraminic acid): dreamful past and exciting future of the newest member of the sialic acid family.

Authors:  Sadako Inoue; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

Review 8.  Metabolic manipulation of glycosylation disorders in humans and animal models.

Authors:  Hudson H Freeze; Vandana Sharma
Journal:  Semin Cell Dev Biol       Date:  2010-04-02       Impact factor: 7.727

9.  Discovery of Novel Putative Inhibitors of UDP-GlcNAc 2-Epimerase as Potent Antibacterial Agents.

Authors:  Yong Xu; Benjamin Brenning; Adrianne Clifford; David Vollmer; Jared Bearss; Carissa Jones; Virgil McCarthy; Chongtie Shi; Bradley Wolfe; Bhasker Aavula; Steve Warner; David J Bearss; Michael V McCullar; Raymond Schuch; Adam Pelzek; Shyam S Bhaskaran; C Erec Stebbins; Allan R Goldberg; Vincent A Fischetti; Hariprasad Vankayalapati
Journal:  ACS Med Chem Lett       Date:  2013-12-12       Impact factor: 4.345

10.  Characterizing non-hydrolyzing Neisseria meningitidis serogroup A UDP-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase using UDP-N-acetylmannosamine (UDP-ManNAc) and derivatives.

Authors:  Lei Zhang; Musleh M Muthana; Hai Yu; John B McArthur; Jingyao Qu; Xi Chen
Journal:  Carbohydr Res       Date:  2015-11-05       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.